CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
-21.52%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$82.4M
AUM Growth
+$82.4M
(-12%)
Cap. Flow
+$9.68M
Cap. Flow
% of AUM
11.75%
Top 10 Holdings %
Top 10 Hldgs %
93.72%
Holding
32
New
4
Increased
11
Reduced
8
Closed
7
Top Buys
| 1 |
KALA BIO
KALA
|
$6.39M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$3.5M |
| 3 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$1.39M |
| 4 |
Investcorp Credit Management BDC
ICMB
|
$832K |
| 5 |
GARS
Garrison Capital Inc.
GARS
|
$676K |
Top Sells
| 1 |
PG&E
PCG
|
$1.04M |
| 2 |
U-Haul Holding Co
UHAL
|
$963K |
| 3 |
JBGS
JBG SMITH
JBGS
|
$655K |
| 4 |
MEI Pharma
MEIP
|
$579K |
| 5 |
Catalyst Pharmaceutical
CPRX
|
$276K |
Sector Composition
| 1 | Healthcare | 68.7% |
| 2 | Financials | 10.95% |
| 3 | Real Estate | 0.94% |
| 4 | Technology | 0.32% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
| $29.6M | 35.89% | 6,604,065 +309,276 | +5% | +$1.39M |
|
|
2
MEI Pharma
MEIP
$160M
| $9.13M | 11.08% | 3,459,124 -219,476 | -6% | -$579K |
|
|
GARS
3
DELISTED
Garrison Capital Inc.
GARS
| $7.83M | 9.5% | 1,217,722 +105,205 | +9% | +$676K |
|
|
4
KALA BIO
KALA
$78.8M
| $6.64M | 8.05% | 1,357,639 +1,306,380 | +2,549% | +$6.39M |
|
|
MTEM
5
DELISTED
Molecular Templates, Inc.
MTEM
| $6.56M | 7.96% | 1,624,241 +25,000 | +2% | +$101K |
|
|
6
Investcorp Credit Management BDC
ICMB
$42.6M
| $6.43M | 7.8% | 1,028,355 +133,182 | +15% | +$832K |
|
7
Alerian MLP ETF
AMLP
$10.7B
| $3.6M | 4.36% | 411,873 -6,543 | -2% | -$57.1K |
|
|
8
SPDR S&P 500 ETF Trust
SPY
$658B
| $3.5M | 4.25% | +14,010 | New | +$3.5M |
|
9
SCYNEXIS
SCYX
$34.9M
| $2.08M | 2.53% | 4,325,000 | – | – |
|
10
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.9M | 2.31% | 9,312 | – | – |
|
|
JBGS
11
JBG SMITH
JBGS
$1.32B
| $778K | 0.94% | 22,349 -18,821 | -46% | -$655K |
|
|
ABDC
12
DELISTED
Alcentra Capital Corp
ABDC
| $487K | 0.59% | 75,303 +17,626 | +31% | +$114K |
|
13
Kura Oncology
KURA
$686M
| $461K | 0.56% | 32,828 -1,880 | -5% | -$26.4K |
|
14
Aclaris Therapeutics
ACRS
$209M
| $453K | 0.55% | 61,264 +21,509 | +54% | +$159K |
|
|
EIGR
15
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $444K | 0.54% | 43,709 +18,215 | +71% | +$185K |
|
16
FS KKR Capital
FSK
$5.11B
| $421K | 0.51% | +81,348 | New | +$421K |
|
|
ARQL
17
DELISTED
Arqule Inc
ARQL
| $345K | 0.42% | 124,435 +34,181 | +38% | +$94.8K |
|
18
Indaptus Therapeutics
INDP
$7.19M
| $318K | 0.39% | 42,236 -22,160 | -34% | -$167K |
|
19
Marker Therapeutics
MRKR
$12M
| $296K | 0.36% | 53,329 -28,211 | -35% | -$157K |
|
20
Ares Capital
ARCC
$15.8B
| $273K | 0.33% | +17,553 | New | +$273K |
|
|
GB
21
DELISTED
Global Blue Group Holding
GB
| $262K | 0.32% | +27,116 | New | +$262K |
|
|
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $219K | 0.27% | 21,034 +48 | +0.2% | +$500 |
|
|
MRNS
23
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $176K | 0.21% | 61,443 +41,263 | +204% | +$118K |
|
|
DRNA
24
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $149K | 0.18% | 13,948 -776 | -5% | -$8.29K |
|
|
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $91K | 0.11% | 123,941 -73,518 | -37% | -$54K |
|